1993
DOI: 10.1007/bf00874149
|View full text |Cite
|
Sign up to set email alerts
|

VRCTC-310 — A novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity

Abstract: Two purified animal venom toxins, crotoxin and cardiotoxin, have been combined to produce a unique natural product (VRCTC-310) currently under investigation as an antitumor agent by the National Cancer Institute. In vitro, it has demonstrated cytotoxic disease specificity and a unique mechanism of action when submitted to COMPARE analysis. In vivo, tolerance was developed to the neurotoxic properties of crotoxin which allowed comparison of several schedules of fixed and escalating daily i.m. doses to mice bear… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0
8

Year Published

1997
1997
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(34 citation statements)
references
References 28 publications
1
23
0
8
Order By: Relevance
“…Antitumor efficacy in vivo, using a daily im administration of CrTX, has been demonstrated on Lewis lung carcinoma (83% growth inhibition) and MX-1 human mammary carcinoma (69% growth inhibition). A lower activity (44% growth inhibition) was observed with HL-60 leukemia cells, suggesting that CrTX may have a certain specificity toward solid tumors [30] .…”
Section: Discussionmentioning
confidence: 94%
“…Antitumor efficacy in vivo, using a daily im administration of CrTX, has been demonstrated on Lewis lung carcinoma (83% growth inhibition) and MX-1 human mammary carcinoma (69% growth inhibition). A lower activity (44% growth inhibition) was observed with HL-60 leukemia cells, suggesting that CrTX may have a certain specificity toward solid tumors [30] .…”
Section: Discussionmentioning
confidence: 94%
“…Current drugs cannot meet the therapeutic needs [6] . Previous study demonstrated that CrTX has cytotoxic effects on A549 cells, which are human lung adenocarcinoma cells with the wild type p53 gene, and shows synergistic effects when combined with Iressa, which is currently a widely-used drug for lung cancer therapy [7,8] .…”
Section: Introductionmentioning
confidence: 99%
“…Además de su citotoxicidad, el efecto anticancerígeno de estas toxinas podría estar relacionado con autofagia de las células tumorales (40). La escasa toxicidad y la ausencia de neurotoxicidad residual de la crotoxina B en estudios con animales, refuerzan su uso en seres humanos como ya ha sido previamente demostrado (35,36,41).…”
Section: Identificación De Proteínasunclassified